Forbes

Nearly 200 blood proteins rise and fall across the menstrual cycle, enabling a test that pinpoints cycle day and links it to risks like fibroids and heavy bleeding.

Eliminating flu and COVID-19 vaccine requirements threatens our military preparedness and goes against data. Will Hegseth go after other vaccine-preventable infections next?

With conflicts escalating in many parts of the world, we're seeing an upsurge in malaria cases and deaths. In some cases, the disease kills more people than the fighting.

In this week’s edition of InnovationRx, we look at the opportunities and challenges of using AI to personalize healthcare and speed up clinical trials, the future of genetic medicine, another big Lilly acquisition, and more.

An overactive immune switch in the placenta may drive preeclampsia; blocking it in models reverses key disease pathways, pointing toward targeted therapies.

Hegseth's decision to allow military servicemembers to refuse flu vaccination contradicts U.S. military doctrine and the lesson of WWI, when flu killed 45,000 U.S. troops

The people who research, make and invest in vaccines are nervous. Some companies have started pulling back on their vaccine work.

A shrimp virus called CMNV has jumped into humans, causing a new eye disease linked to handling and eating raw seafood. The virus is already global.

Elevance Health reported $1.7 billion in first quarter net income as cost issues continued to drag on earnings of the nation’s second-largest health insurer.

The UK just banned cigarette sales to anyone born after 2008. A doctor explains what the landmark Tobacco and Vapes Bill does — and whether the US could ever follow suit.

False reports, including a fake CNN screenshot, are circulating on social media, claiming that a product based on honey can cure Alzheimer's disease.

UnitedHealth Group reported first quarter net income of $6.3 billion as medical costs fell, triggering an improved outlook for the rest of the year.

Americans are using AI even as they distrust it. For public health leaders, the bigger risk isn’t the technology—it’s failing to engage with it and shape how it’s used.